The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lyssikatos Joseph P since 2023.
This trader's CIK number is 1967150.
At the time of last reporting, Lyssikatos Joseph P was the CHIEF SCIENTIFIC OFFICER of Enliven Therapeutics, Inc.. (stock ticker symbol ELVN).
Also see all insider trading activities at Enliven Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ELVN | 0 | $0 | 75,000 | $1,519,504 | 0 | $0 |
| 2024 | ELVN | 0 | $0 | 203,847 | $4,748,647 | 102,000 | $114,240 |
| 2023 | ELVN | 0 | $0 | 36,000 | $476,685 | 36,000 | $40,318 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-21 | ELVN | Sale | 7,500 | 20.01 | 150,097 |
| 2025-08-19 | ELVN | Sale | 5,000 | 19.62 | 98,120 |
| 2025-07-21 | ELVN | Sale | 12,500 | 22.58 | 282,237 |
| 2025-06-20 | ELVN | Sale | 12,500 | 21.40 | 267,462 |
| 2025-06-03 | ELVN | Sale | 7,500 | 20.03 | 150,217 |
| 2025-05-19 | ELVN | Sale | 5,000 | 16.31 | 81,535 |
| 2025-05-02 | ELVN | Sale | 2,470 | 20.01 | 49,424 |
| 2025-05-01 | ELVN | Sale | 5,030 | 20.07 | 100,967 |
| 2025-04-21 | ELVN | Sale | 5,000 | 16.37 | 81,870 |
| 2025-03-19 | ELVN | Sale | 12,500 | 20.61 | 257,575 |
| 2024-10-18 | ELVN | Sale | 847 | 30.00 | 25,412 |
| 2024-10-09 | ELVN | Sale | 37,878 | 28.32 | 1,072,704 |
| 2024-10-08 | ELVN | Sale | 13,267 | 28.24 | 374,607 |
| 2024-10-04 | ELVN | Sale | 7,522 | 27.51 | 206,937 |
| 2024-10-07 | ELVN | Sale | 2,707 | 27.61 | 74,726 |
| 2024-10-01 | ELVN | Sale | 527 | 27.54 | 14,511 |
| 2024-08-29 | ELVN | Sale | 12,000 | 22.78 | 273,384 |
| 2024-07-31 | ELVN | Sale | 3,099 | 27.56 | 85,399 |
| 2024-07-29 | ELVN | Sale | 12,000 | 27.06 | 324,708 |
| 2024-07-01 | ELVN | Sale | 12,000 | 22.89 | 274,740 |
| 2024-05-29 | ELVN | Option Ex | 12,000 | 1.12 | 13,440 |
| 2024-05-29 | ELVN | Sale | 12,000 | 22.04 | 264,516 |
| 2024-04-29 | ELVN | Sale | 12,000 | 18.17 | 218,075 |
| 2024-04-29 | ELVN | Option Ex | 12,000 | 1.12 | 13,440 |
| 2024-04-11 | ELVN | Option Ex | 30,000 | 1.12 | 33,600 |
| 2024-04-11 | ELVN | Sale | 30,000 | 25.04 | 751,320 |
| 2024-04-01 | ELVN | Option Ex | 12,000 | 1.12 | 13,440 |
| 2024-04-01 | ELVN | Sale | 12,000 | 18.63 | 223,548 |
| 2024-02-29 | ELVN | Sale | 12,000 | 16.70 | 200,352 |
| 2024-02-29 | ELVN | Option Ex | 12,000 | 1.12 | 13,440 |
| 2024-01-29 | ELVN | Option Ex | 12,000 | 1.12 | 13,440 |
| 2024-01-29 | ELVN | Sale | 12,000 | 15.86 | 190,260 |
| 2023-12-29 | ELVN | Option Ex | 12,000 | 1.12 | 13,440 |
| 2023-12-29 | ELVN | Sale | 12,000 | 14.45 | 173,448 |
| 2023-12-22 | ELVN | Sale | 6,546 | 13.07 | 85,530 |
| 2023-12-21 | ELVN | Sale | 20 | 13.00 | 260 |
| 2023-12-22 | ELVN | Option Ex | 6,546 | 1.12 | 7,331 |
| 2023-12-21 | ELVN | Option Ex | 20 | 1.12 | 22 |
| 2023-12-20 | ELVN | Sale | 8,688 | 13.01 | 113,048 |
| 2023-12-19 | ELVN | Sale | 200 | 13.00 | 2,600 |
| 2023-12-20 | ELVN | Option Ex | 8,688 | 1.12 | 9,730 |
| 2023-12-19 | ELVN | Option Ex | 200 | 1.12 | 224 |
| 2023-11-03 | ELVN | Option Ex | 8,546 | 1.12 | 9,571 |
| 2023-11-03 | ELVN | Sale | 8,546 | 13.08 | 111,747 |
| 2023-09-29 | ELVN | Option Ex | 12,000 | 1.12 | 13,440 |
| 2023-09-29 | ELVN | Sale | 12,000 | 13.62 | 163,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER of Enliven Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.